Table 1 Baseline characteristics
Al Patients | Intervention | Controls | P-value* | ||||
|---|---|---|---|---|---|---|---|
8,893 | 1,330 | 7,563 | |||||
Female Sex | 70.73% | 67.44% | 71.31% | 0.004 | |||
Age | 83.09 | 10.84 | 79.01 | 11.68 | 83.81 | 10.52 | < 0.001 |
< 65 | 6.34% | 13.01% | 5.17% | < 0.001 | |||
65–75 | 7.01% | 13.01% | 5.95% | ||||
75–85 | 34.51% | 37.67% | 33.95% | ||||
85–95 | 44.08% | 32.48% | 46.12% | ||||
≥ 95 | 8.06% | 3.83% | 8.81% | ||||
Level of care | |||||||
0–1 | 12.16% | 23.91% | 10.09% | < 0.001 | |||
2 | 16.87% | 16.99% | 16.85% | ||||
3 | 27.03% | 24.21% | 27.53% | ||||
4 | 29.03% | 24.51% | 29.83% | ||||
5 | 14.91% | 10.38% | 15.71% |